To identify the functional characterisation of XIAP in AML cells, siRNAs were designed to knockdown XIAP (Figure S3A,B) and birinapant, a Smac‐mimetic IAP‐antagonist was used to inhibit the expression of XIAP. This evidence concerns the gene XIAP and acute myeloid leukemia.